2025-05-14T14:54:52-05:00 2024-06-30 991856619 GRANT THORNTON ADVISORS LLC 5955 TG LEE BOULEVARD SUITE 200 ORLANDO FL 32801 990 2023-07-01 593238640 H LEE MOFFITT CANCER CENTER & RESEARCH INST LIFETIME CANCER SCREENING CTR INC HLEE 8137454673 12902 MAGNOLIA DRIVE TAMPA FL 33612 JOANNA WEISS EVP/CFO 8137451188 2025-05-14 1 0 MICHELE N MELCHIOR P00488037 4074815100 2023 2025-03-06 01:10:19Z MOFFITT MEDICAL GROUP KAREN LU 12902 MAGNOLIA DRIVE TAMPA FL 33612 145660440 0 X HTTPS://MOFFITT.ORG/ABOUT-MOFFITT/MEDICAL/ X 1994 FL TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBS. 11 11 1296 13 9993056 346270 1966479 1767633 132351894 143829512 0 0 10925 63295 134329298 145660440 6500 0 0 0 267749943 309623343 0 0 0 28758241 31380666 296514684 341004009 -162185386 -195343569 15261265 16567329 18131939 20499180 -2870674 -3931851 X TO PROMOTE AND SUPPORT H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC (INSTITUTE), H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL (HOSPITAL), AND H. LEE MOFFITT CANCER FOUNDATION BY EMPLOYING PHYSICIANS WHO STAFF THE HOSPITAL, BY MANAGING THEIR PRACTICE AND BY EMPLOYING THE CLINICAL SCIENTISTS WHO PROVIDE CLINICAL RESEARCH SERVICES. 0 0 305667059 133836456 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") EMPLOYS THE PHYSICIANS (KNOWN AS THE MOFFITT MEDICAL GROUP) THAT STAFF THE HOSPITAL AND PROVIDE CLINICAL RESEARCH SERVICES TO THE CANCER CENTER HEALTH CARE SYSTEM. THE PROVISION OF PRACTICE MANAGEMENT SERVICES TO ITS EMPLOYED PHYSICIANS AND CLINICAL SCIENTISTS ENHANCES THE EFFICIENCY OF HEALTHCARE AND RESEARCH SERVICES PROVIDED BY THESE EMPLOYEES. THIS BENEFITS ALL ENTITIES IN THE CANCER CENTER HEALTH CARE SYSTEM AND PROMOTES AND SUPPORTS THE RESEARCH AND ACADEMIC MISSIONS OF THE CANCER CENTER HEALTH CARE SYSTEM. 305667059 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 25 0 1 1296 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 11 1 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 1 0 0 0 X JOANNA WEISS 8137451188 12902 MAGNOLIA DR TAMPA FL 33612 X HUGO FERNANDEZ MD DIR, DEPT CHAIR MAL HEM (NON-VOTING) 56.00 0.00 X 833439 0 235346 NIKHIL KHUSHALANI DIR, SR MBR HEMONCMED (NON-VOTING) 51.00 0.00 X 546257 0 158550 SUSAN VADAPARAMPIL DIRECTOR (NON-VOTING) 1.00 55.00 X 0 420905 246515 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER TO 5/17/24 9.00 47.00 X 0 1042682 397146 G DOUGLAS LETSON PRES, EVP-PIC TO 6/2/24 21.00 34.00 X 0 1073620 302795 L DAVID DE LA PARTE EVP-GEN COUNSEL; ASST SEC TO 6/11/24 9.00 47.00 X 0 865274 392072 JOANNA WEISS CFAO & ASST TREASURER AS OF 5/19/24 8.00 47.00 X 0 528314 191655 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 30.00 25.00 X 0 442172 252329 HENRY REYES VP-PARTNERSHIP DEV TO 4/12/24 9.00 46.00 X 0 403439 72651 EVAN ZASLOW VP PAYER STRATEGIES 20.00 35.00 X 0 389889 63653 KAREN LU PRES, EVP-PIC AS OF 6/3/24 21.00 34.00 X 0 0 0 PETER JOHNSTONE DEPT CHAIR RADIATION ONCOLOGY 55.00 0.00 X 805189 0 429732 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 902550 0 233381 JOHN A ARRINGTON VICE CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 721114 0 342091 DONALD L KLIPPENSTEIN VICE CHAIR DIAGNOSTIC IMAGING 55.00 0.00 X 689441 0 258143 KOSJ YAMOAH DEPT CHAIR RADIATION ONCOLOGY 55.00 0.00 X 804983 0 141181 SEPHALIE PATEL DEPT CHAIR ANESTHESIOLOGY 55.00 0.00 X 544307 0 141390 JONATHAN COHEN VICE CHAIR ANESTHESIOLOGY 55.00 0.00 X 480817 0 195727 NASRIN ALDAWOODI VICE CHAIR ANESTHESIOLOGY 55.00 0.00 X 499272 0 90557 LARY ROBINSON SR MBR THORCARDIO 50.00 0.00 X 974179 0 747397 JULIO M POW-SANG MD DEPT CHAIR GU 55.00 0.00 X 1002128 0 241993 MICHAEL A VOGELBAUM PRG LDR NEURO ONCOLOGY 55.00 0.00 X 1038509 0 145291 NAM TRAN SR MBR NEUROSURG 50.00 0.00 X 963864 0 157868 JASON B FLEMING DEPT CHAIR GI TUMOR 55.00 0.00 X 974044 0 112978 LOUIS B HARRISON FRM VP CHIEF PART OFF AS OF 2/28/21 50.00 0.00 X 145402 0 61514 DAVID N THRUSH FRM DEPT CHAIR ANESTH AS OF 6/24/23 50.00 0.00 X 740208 0 338321 FRANK CAPITANO DIRECTOR, CHAIR 1.00 0.00 X X 0 0 0 ALLAN S MARTIN DIRECTOR, IMMED PAST CHAIR 1.00 0.00 X X 0 0 0 VICTOR YOUNG DIRECTOR, VICE CHAIR 1.00 0.00 X X 0 0 0 THE HON H LEE MOFFITT ESQ DIRECTOR, SECRETARY/TREAS 1.00 2.00 X X 0 0 0 JOEDRECKA BROWN SPEIGHTS MD DIRECTOR 1.00 0.00 X 0 0 0 KATHERINE CHUNG-BRIDGES DIRECTOR 1.00 0.00 X 0 0 0 MARK WATSON DIRECTOR 1.00 0.00 X 0 0 0 MICHAEL O'MALLEY DIRECTOR 1.00 0.00 X 0 0 0 REGINALD GOINS DIRECTOR 1.00 1.00 X 0 0 0 ROBERT J PEREZ DIRECTOR 1.00 0.00 X 0 0 0 THE HON MARK A PIZZO ESQ DIRECTOR 1.00 1.00 X 0 0 0 12665703 5166295 5950276 806 1 1 0 EMATB LLC 2502 W SAINT ISABEL ST TAMPA FL 336076318 OUTSOURCED CLINICAL SERVICES 3216607 UMSA 12901 BRUCE B DOWNS BLVD TAMPA FL 33612 OUTSOURCED CLINICAL SERVICES 1422012 BUCHANAN INGERSOLL 501 E KENNEDY BLVD STE 2400 TAMPA FL 336025236 LEGAL SERVICES 1365443 MEDICAL DOCTOR ASSOCIATES LLC 145 TECHNOLOGY PKWY NORCROSS GA 300922913 TEMPORARY LABOR 800892 LOCUMTENENS 2655 NORTHWINDS PKWY ALPHARETTA GA 300092280 TEMPORARY LABOR 455077 6 1836 1765797 1767633 NET PATIENT SERVICE REVENUE 541900 132964836 132964836 MANAGEMENT SERVICES 541610 10132256 139200 9993056 PHYSICIAN AFFILIATE FEES 541900 373062 373062 QUALITY IMPROVEMENT PROGRAM 541900 286607 286607 CHART/SLIDE REVIEW REIMBURSEMENT 541900 62485 62485 10266 10266 143829512 REIMBURSEMENT 900099 50000 50000 INTEREST FROM INS CO 524298 13295 13295 63295 145660440 133836456 9993056 63295 X 7574742 7403944 170798 793904 776003 17901 258030286 237501058 20529228 15186228 14253493 932735 13957025 12874093 1082932 14081158 12811075 1270083 818740 818740 45190 45190 6551005 4943352 1607653 2540791 72860 2467931 948163 91274 856889 7407954 7407954 1997924 40321 1957603 919597 423400 496197 292176 292176 1326010 1326010 2129673 2129673 ALLOC OF I/C EXPENSES 0 8902295 -8902295 BAD DEBT EXPENSES 2354457 2354457 0 PROFESSIONAL DVLPMNT 2217242 2136647 80595 RECRUITMENT 1128530 851839 276691 703214 230948 472266 341004009 305667059 35336950 0 15217951 16285530 42880 281573 101309 101083 434 226 15261265 16567329 18131939 20499180 18131939 20499180 X -2870674 -3931851 -2870674 -3931851 15261265 16567329 X -195343569 194282392 X 0 1 X 1 0 X 3651777 1704551 1277920 1966479 1767633 10368360 93262302 102282293 115157808 123797991 133836456 568336850 96914079 103986844 116435728 125764470 135604089 578705210 0 0 0 578705210 301419 457935 549563 347270 1656187 746375 185964 21300 10925 63295 1027859 97961873 104630743 117006591 125775395 136014654 581389256 0.99540 0.98170 0.00000 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: REIMBURSEMENT - 2023 AMOUNT: $ 50,000. INTEREST FROM INS CO - 2019 AMOUNT: $ 12,931. 2020 AMOUNT: $ 8,631. 2021 AMOUNT: $ 21,300. 2022 AMOUNT: $ 10,925. 2023 AMOUNT: $ 13,295. HONORARIUM - 2019 AMOUNT: $ 750. MISC - 2020 AMOUNT: $ 238. TAX REFUND - 2019 AMOUNT: $ 732,694. 2020 AMOUNT: $ 177,095. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 101309 101083 226 226 X PART X, LINE 2: H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. DID NOT HAVE ANY UNCERTAIN POSITIONS IN ITS AUDITED FINANCIAL STATEMENTS. THE ASC-740 FOOTNOTE READS AS FOLLOWS: SIGNIFICANT JUDGMENT IS REQUIRED TO EVALUATE UNCERTAIN TAX POSITIONS. THE CANCER CENTER EVALUATES ITS UNCERTAIN TAX POSITIONS ON A REGULAR BASIS. ITS EVALUATIONS ARE BASED ON A NUMBER OF FACTORS, INCLUDING CHANGES IN FACTS AND CIRCUMSTANCES, CHANGES IN TAX LAW, AND CORRESPONDENCE WITH TAX AUTHORITIES. THE CANCER CENTER ACCOUNTS FOR UNCERTAIN TAX POSITIONS BY RECOGNIZING A TAX BENEFIT OR LIABILITY AT THE LARGEST AMOUNT THAT, IN ITS JUDGMENT, IS MORE THAN 50% LIKELY TO BE REALIZED OR PAID BASED UPON TECHNICAL MERITS OF THE POSITION. THE CANCER CENTER CURRENTLY HAS NO TAX BENEFITS OR LIABILITIES RELATED TO UNCERTAIN TAX POSITIONS. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SEMINARS 71923 EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 0 0 PROGRAM SERVICES SEMINARS 5640 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES SEMINARS 17733 CENTRAL AMERICA AND THE CARIBBEAN - ANTIGUA & BARBUDA, ARUBA, BAHAMAS, 0 0 PROGRAM SERVICES SEMINARS 4952 SOUTH ASIA - AFGHANISTAN, BANGLADESH, BHUTAN, INDIA, MALDIVES, NEPAL, 0 1 MAINTAINING OFFICES, EMPLOYEES OR AGENTS 49321 0 1 0 0 0 1 149569 0 149569 0 0 0 0 0 0 PART I, LINE 3: ACCRUAL METHOD OF ACCOUNTING WAS USED TO ACCOUNT FOR EXPENDITURES ON SCHEDULE F CONSISTENT WITH THE AUDITED FINANCIAL STATEMENTS. 0 1 0 0 0 1 1 0 0 LARY ROBINSON SR MBR THORCARDIO 867131 0 78975 0 28073 0 735910 0 14754 0 1724843 0 0 0 YVETTE M LYONS TREMONTI EVP-CFAO & ASST TREASURER TO 5/17/24 0 772296 0 212568 0 57818 0 362337 0 38529 0 1443548 0 0 G DOUGLAS LETSON PRES, EVP-PIC TO 6/2/24 0 789810 0 219602 0 64208 0 281091 0 27218 0 1381929 0 0 L DAVID DE LA PARTE EVP-GEN COUNSEL; ASST SEC TO 6/11/24 0 643431 0 178715 0 43128 0 365841 0 29834 0 1260949 0 0 JULIO M POW-SANG MD DEPT CHAIR GU 721631 0 269603 0 10894 0 219515 0 25954 0 1247597 0 0 0 PETER JOHNSTONE DEPT CHAIR RADIATION ONCOLOGY 721420 0 72875 0 10894 0 428129 0 10385 0 1243703 0 0 0 MICHAEL A VOGELBAUM PRG LDR NEURO ONCOLOGY 930893 0 100092 0 7524 0 113768 0 35244 0 1187521 0 0 0 ROBERT A GATENBY DEPT CHAIR DIAGNOSTIC IMAGING 719761 0 171151 0 11638 0 211676 0 25042 0 1139268 0 0 0 NAM TRAN SR MBR NEUROSURG 814731 0 144231 0 4902 0 157275 0 8792 0 1129931 0 0 0 JASON B FLEMING DEPT CHAIR GI TUMOR 787540 0 181602 0 4902 0 81219 0 36853 0 1092116 0 0 0 DAVID N THRUSH FRM DEPT CHAIR ANESTH AS OF 6/24/23 589950 0 139364 0 10894 0 324594 0 17203 0 1082005 0 0 0 HUGO FERNANDEZ MD DIR, DEPT CHAIR MAL HEM (NON-VOTING) 678790 0 147125 0 7524 0 213642 0 25424 0 1072505 0 0 0 JOHN A ARRINGTON VICE CHAIR DIAGNOSTIC IMAGING 650728 0 59492 0 10894 0 320386 0 28046 0 1069546 0 0 0 DONALD L KLIPPENSTEIN VICE CHAIR DIAGNOSTIC IMAGING 624568 0 55599 0 9274 0 236697 0 25166 0 951304 0 0 0 KOSJ YAMOAH DEPT CHAIR RADIATION ONCOLOGY 627179 0 171664 0 6140 0 108157 0 36744 0 949884 0 0 0 JOANNA WEISS CFAO & ASST TREASURER AS OF 5/19/24 0 407594 0 94914 0 25806 0 158381 0 36877 0 723572 0 0 NIKHIL KHUSHALANI DIR, SR MBR HEMONCMED (NON-VOTING) 480345 0 61672 0 4240 0 124291 0 37945 0 708493 0 0 0 KAREN WARTENBERG VP MOFFITT MEDICAL GROUP 0 347969 0 78582 0 15621 0 250821 0 4906 0 697899 0 0 SEPHALIE PATEL DEPT CHAIR ANESTHESIOLOGY 486746 0 56535 0 1026 0 130805 0 14239 0 689351 0 0 0 JONATHAN COHEN VICE CHAIR ANESTHESIOLOGY 428286 0 51086 0 1445 0 163969 0 35376 0 680162 0 0 0 SUSAN VADAPARAMPIL DIRECTOR (NON-VOTING) 0 338079 0 64237 0 18589 0 213242 0 37378 0 671525 0 0 NASRIN ALDAWOODI VICE CHAIR ANESTHESIOLOGY 418467 0 79833 0 972 0 59206 0 35568 0 594046 0 0 0 HENRY REYES VP-PARTNERSHIP DEV TO 4/12/24 0 323128 0 75464 0 4847 0 50947 0 27932 0 482318 0 0 EVAN ZASLOW VP PAYER STRATEGIES 0 314903 0 74264 0 722 0 29422 0 37940 0 457251 0 0 LOUIS B HARRISON FRM VP CHIEF PART OFF AS OF 2/28/21 136980 0 0 0 8422 0 61149 0 365 0 206916 0 0 0 PART I, LINE 3 LCS RELIES ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, A RELATED ORGANIZATION WHICH USES AN INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEYS OR STUDIES, AN EXECUTIVE COMPENSATION COMMITTEE, AND THE APPROVAL BY THE BOARD OR THE EXECUTIVE COMPENSATION COMMITTEE OF THE BOARD, TO ESTABLISH THE PHYSICIAN IN CHIEF/PRESIDENT'S AND TOP MANAGEMENT OFFICIALS' COMPENSATION. PART I, LINE 4B TO BE ELIGIBLE TO PARTICIPATE IN THE 457(F) NON-QUALIFIED SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP), PARTICIPANTS MUST ELECT TO CONTRIBUTE AT LEAST 10% ACROSS THE 403(B) AND 457(B) PLANS, AND ARE VESTED AFTER 10 YEARS OF SERVICE. LUMP SUM DISTRIBUTIONS FROM THE ACCOUNT ARE MADE UPON NORMAL RETIREMENT OR TERMINATION. BELOW ARE INDIVIDUALS LISTED ON LCS'S 2023 FORM 990 PART VII, SECTION A, THAT PARTICIPATED IN THE 457(F) SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN AND THEIR RESPECTIVE AMOUNTS OF COMPENSATION CONSTRUCTIVELY RECEIVED IN TAX YEAR 2023 FROM THE PLAN: JOHN ARRINGTON - $1,750 LOUIS D. DE LA PARTE - $32,791 ROBERT A. GATENBY - $1,750 LOUIS B HARRISON - $8,422 PETER A. JOHNSTONE - $1,750 NIKHIL I. KHUSHALANI - $1,750 DONALD L. KLIPPENSTEIN - $1,750 G. D. LETSON - $46,459 YVETTE M. LYONS TREMONTI - $45,116 JULIO M. POW-SANG - $1,750 LARY ROBINSON - $1,750 DAVID THRUSH - $1,750 SUSAN VADAPARAMPIL - $16,836 MICHAEL A. VOGELBAUM - $0 KAREN WARTENBERG - $12,904 JOANNA WEISS - $24,396 KOSJ YAMOAH - $5,000 EVAN ZASLOW-$0 PART I, LINE 6 IN GENERAL, INCENTIVE COMPENSATION IS BASED ON MOFFITT'S ACHIEVEMENT AGAINST SPECIFIC ORGANIZATIONAL GOALS RELATED TO NET OPERATING INCOME AND ON DIVISION OR INDIVIDUAL GOALS. NET OPERATING INCOME MUST MEET OR EXCEED A CERTAIN THRESHOLD IN ORDER TO TRIGGER A PAYOUT FOR THE ORGANIZATIONAL GOAL COMPONENTS. FORM 990, PART VI, SECTION A, LINE 2 THE FOLLOWING DIRECTORS AND OFFICERS, THAT JOINTLY SERVE ON H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE LIFETIME CANCER SCREENING CENTER, INC. ("LCS") AND A FOR-PROFIT RELATED ENTITY, QUALIFY AS HAVING A BUSINESS RELATIONSHIP. LCS & MOFFITT TECHNOLOGIES CORPORATION: YVETTE LYONS TREMONTI, OFFICER LOUIS D. DE LA PARTE, OFFICER LOUIS HARRISON OWNS 50% OF THE SHARES AND IS PRESIDENT/CEO OF MYCAREGORITHM LLC, WHERE ALLAN MARTIN SERVES AS AN ADVISOR AND JASON FLEMING, KOSJ YAMOAH AND JULIO POW-SANG ARE INDEPENDENT CONTRACTORS AS FACULTY EXPERTS. MYCAREGORITHM LLC DOES NOT HAVE A BUSINESS RELATIONSHIP WITH LCS. FORM 990, PART VI, SECTION A, LINE 6 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. IS THE SOLE MEMBER OF LCS. FORM 990, PART VI, SECTION A, LINE 7A AS THE SOLE MEMBER OF LCS, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (THE INSTITUTE) SHALL HAVE THE POWER TO APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF LCS. FORM 990, PART VI, SECTION A, LINE 7B THE INSTITUTE (AS SOLE MEMBER) SHALL ALSO HAVE THE FOLLOWING POWERS: A. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE ARTICLES OF INCORPORATION OF THE CORPORATION; B. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION, CHANGE, AMENDMENT OR REPEAL OF THE BYLAWS OF THE CORPORATION; C. APPROVE, DISAPPROVE OR RECOMMEND THE SELECTION OF A QUALIFIED AUDIT FIRM AND THE ANNUAL OPERATING AND CAPITAL BUDGETS OF THE CORPORATION; D. EITHER APPROVE OR DISAPPROVE THE TRANSFER, SALE, LEASE OR DISPOSITION OF ANY ASSET OF THE CORPORATION IN EXCESS OF TWO HUNDRED THOUSAND DOLLARS ($200,000.00); E. APPROVE OR DISAPPROVE THE CONFERRING OF ANY LIEN OR SECURITY INTEREST IN ASSETS OF THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00), WHETHER SAME SHALL BE IN CONNECTION WITH EITHER PUBLIC OR PRIVATE FINANCING, OR OTHERWISE; F. APPROVE OR DISAPPROVE ALL DONATIONS OR CHARITABLE CONTRIBUTIONS BY THE CORPORATION IN EXCESS OF TWENTY THOUSAND DOLLARS ($20,000.00) PER CONTRIBUTION OR ANNUAL CONTRIBUTION EXCEEDING FIFTY THOUSAND DOLLARS ($50,000.00) IN THE AGGREGATE; G. APPROVE, DISAPPROVE OR RECOMMEND THE ADOPTION OF THE CORPORATION'S MISSION AND PHILOSOPHY STATEMENT; H. APPROVE OR DISAPPROVE CAPITAL EXPENDITURES BY THE CORPORATION IN EXCESS OF ONE MILLION DOLLARS ($1,000,000.00) PER EXPENDITURE OR ONE MILLION DOLLARS ($1,000,000.00) IN THE AGGREGATE ANNUALLY; AND I. APPROVE, DISAPPROVE OR REMOVE ANY MEMBER OF THE BOARD OF DIRECTORS OR OFFICER OF THE CORPORATION. FORM 990, PART VI, SECTION A, LINE 8B LCS DOES NOT HAVE A COMMITTEE WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11B PRIOR TO ELECTRONICALLY FILING FORM 990 (RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX), A COPY OF THE RETURN IS PROVIDED TO THE JOINT FINANCE COMMITTEE, CONSISTING OF BOARD MEMBERS ACROSS THE CANCER CENTER, GIVING EACH MEMBER TIME TO REVIEW THE RETURN. BOARD MEMBERS HAVE THE OPPORTUNITY TO ASK QUESTIONS RELATED TO THE INFORMATION PROVIDED ON THE RETURN. LCS' FORM 990 IS ALSO PROVIDED TO THE CHIEF FINANCIAL OFFICER FOR REVIEW. BASED ON THE REVIEW ANY SUGGESTED COMMENTS OR CHANGES ARE DISCUSSED, AND IF DEEMED NECESSARY CHANGES ARE MADE PRIOR TO SIGNING. FORM 990, PART VI, SECTION B, LINE 12C H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC., THE INSTITUTE AND PARENT ORGANIZATION OF THE CANCER CENTER, DEVELOPS, IMPLEMENTS, AND ENFORCES COMPANY POLICY FOR THE CANCER CENTER AS A WHOLE. ON AN ANNUAL BASIS A PRESENTATION IS MADE TO ALL BOARD MEMBERS THROUGHOUT MOFFITT'S ENTITIES, INCLUDING LCS' BOARD MEMBERS, TO REVIEW THE CONFLICT OF INTEREST POLICY AND PROCEDURES FOR DISCLOSING ANY POTENTIAL CONFLICTS. EACH DIRECTOR, OFFICER, COMMITTEE MEMBER, AND KEY EMPLOYEE SHALL COMPLETE A CONFLICT OF INTEREST DISCLOSURE CERTIFICATION VIA THE ELECTRONIC DISCLOSURE SYSTEM. ANY DIRECTOR, OFFICER, COMMITTEE MEMBER, OR KEY EMPLOYEE WHO REASONABLY BELIEVES THAT HE OR SHE MAY HAVE AN ACTUAL OR POTENTIAL CONFLICT OF INTEREST MUST DISCLOSE THE EXISTENCE OF AND THE MATERIAL FACTS OF THE NATURE OF HIS/HER INTEREST ON THE FORM. THE ELECTRONIC FORM IS SUBMITTED TO THE CORPORATE COMPLIANCE OFFICE, WHICH REVIEWS THE FORMS, GATHERS ADDITIONAL RELEVANT INFORMATION WHERE NECESSARY, AND PREPARES A SUMMARY OF THE DISCLOSURES TO BE REVIEWED BY THE CONFLICT OF INTEREST WORK GROUP. IF A DIRECTOR OR COMMITTEE MEMBER DISCLOSES THAT HE/SHE HAS A POTENTIAL CONFLICT OF INTEREST AT A BOARD OR COMMITTEE MEETING, SUCH DIRECTOR OR COMMITTEE MEMBER MUST DISCLOSE THE NATURE OF THE INTEREST AND ANY RELATED INFORMATION AND RESPOND TO QUESTIONS AS MAY BE REQUIRED BY THE REMAINING MEMBERS. BASED ON THE INFORMATION DISCLOSED, THE REMAINING BOARD MEMBERS WILL DETERMINE WHETHER A CONFLICT OF INTEREST EXISTS. IF A CONFLICT EXISTS THE BOARD OR COMMITTEE SHALL DETERMINE WHETHER AN ALTERNATIVE TRANSACTION OR ARRANGEMENT THAT WOULD NOT GIVE RISE TO A CONFLICT IS EQUALLY ADVANTAGEOUS. IF AN ALTERNATIVE TRANSACTION IS NOT EQUALLY ADVANTAGEOUS THE DIRECTOR OR COMMITTEE MEMBER WHO IS THE SUBJECT OF THE CONFLICT SHALL NOT VOTE ON, NOR USE HIS HER PERSONAL INFLUENCE ON, NOR PARTICIPATE IN DISCUSSIONS OR DELIBERATIONS WITH RESPECT TO THE TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15 THE INSTITUTE HAS AN ESTABLISHED SUB-COMMITTEE, THE JOINT EXECUTIVE COMPENSATION & BENEFITS COMMITTEE (JEC&BC) THAT IS MADE UP ENTIRELY OF INDEPENDENT, OUTSIDE COMMITTEE MEMBERS. THIS COMMITTEE IS CHARGED WITH THE OVERSIGHT OF THE COMPENSATION OF MOFFITT DISQUALIFIED PERSONS. THESE POSITIONS INCLUDE THE CEO, EXECUTIVE VICE PRESIDENTS, CHIEF HUMAN RESOURCES OFFICER, CHIEF ENTERPRISE RISK OFFICER, VP FINANCE, VP MOFFITT MEDICAL GROUP, VP PATIENT CARE SERVICES/CHIEF NURSING OFFICER AND VP CHIEF PHARMACY OFFICER. TO ACCOMPLISH ITS MISSION, THE COMMITTEE CAN, AS NEEDED, AND DOES AT ITS DISCRETION, ENGAGE INDEPENDENT OUTSIDE ADVISORS, INCLUDING, BUT NOT LIMITED TO ATTORNEYS AND THIRD-PARTY COMPENSATION CONSULTANTS. ON AN ANNUAL BASIS THE JEC&BC ENGAGES A NATIONALLY KNOWN, THIRD-PARTY CONSULTING FIRM TO PROVIDE A DETAILED STUDY OF THE CASH COMPENSATION FOR EACH DISQUALIFIED PERSON. THE CONSULTANT USES A VARIETY OF PUBLISHED SURVEYS COMPILED BY INDEPENDENT FIRMS TO PROVIDE THE INSTITUTE SOURCE DATA FOR THE STUDY. USING FUNCTIONALLY COMPARABLE POSITIONS IN OTHER SIMILARLY SIZED, NOT-FOR-PROFIT AND FOR-PROFIT HEALTHCARE, ACADEMIC AND RESEARCH ORGANIZATIONS, THE CONSULTING FIRM PRODUCES A STUDY THAT COMPARES EACH DESIGNATED MOFFITT POSITION TO ITS APPROPRIATE MARKET EQUIVALENT, INCLUDING THE VALUE OF ALL BENEFITS AND PERQUISITES (CASH AND NON-CASH) PROVIDED AS COMPENSATION TO THE DISQUALIFIED PERSONS. THE RESULTING DATA IS PROVIDED TO THE DIRECTOR OF COMPENSATION, WHO IS NOT INCLUDED IN THE DISQUALIFIED PERSON CATEGORY, FOR USE IN THE FORMULATION OF RECOMMENDATIONS FOR COMPENSATION CHANGES TO MAINTAIN MARKET COMPETITIVENESS OR TO REWARD PERFORMANCE. THESE RECOMMENDATIONS, ALONG WITH THE CONSULTANT'S COMPARABILITY DATA, ARE PRESENTED TO THE JEC&BC FOR THE COMMITTEE MEMBERS TO CONFIRM ITS REASONABLENESS, MAKE MODIFICATIONS AS IT DEEMS NECESSARY AND PROVIDE FINAL APPROVAL. MINUTES ARE KEPT AT EACH OF THESE ANNUAL MEETINGS DETAILING THE RECOMMENDATIONS PRESENTED AND THE DECISIONS MADE BY THE COMMITTEE. THESE MINUTES ARE PUBLISHED TO THE COMMITTEE AT THE NEXT MEETING AND REPORTED BACK TO THE INSTITUTE BOARD. FORM 990, PART VI, SECTION C, LINE 19 LCS MAKES AVAILABLE ITS CONSOLIDATED AUDITED FINANCIAL STATEMENTS TO THE PUBLIC THROUGH DACBOND, A THIRD PARTY VENDORS' WEBSITES. IN ADDITION, FORM 990 IS MADE AVAILABLE ON GUIDESTAR AS WELL AS MOFFITT'S WEBSITE. ALL ORGANIZING AND GOVERNING DOCUMENTS SUCH AS FORM 1023, CONFLICTS OF INTEREST POLICY, AND BYLAWS AS WELL AS FORM 990 AND AUDITED FINANCIAL STATEMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VII, SECTION A, LINE 1A: EMPLOYEES WHO ARE LISTED ON MOFFITT LCS'S FORM 990 ARE EMPLOYEES WHOSE W-2'S WERE ISSUED BY THE INSTITUTE, THE COMMON PAYMASTER AND RELATED ENTITY. PROCEDURES TO REPORT COMPENSATION OF EMPLOYEES ON FORM 990 PART VII AND ON SCHEDULE J ARE IN ACCORDANCE WITH IRS INSTRUCTIONS FOR EACH RESPECTIVE SECTION. FORM 990, PART IX, COLUMN (D): THERE ARE NO FUNDRAISING EXPENSES BECAUSE H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE FOUNDATION, INC. HANDLES ALL FUNDRAISING ACTIVITIES FOR H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. AND ITS SUBSIDIARIES. FORM 990, PART IX, LINE 24A: CERTAIN MOFFITT CANCER CENTER'S INTERCOMPANY OVERHEAD HAS BEEN ALLOCATED FROM THE PARENT (INSTITUTE) ENTITY TO LCS AND THOSE AMOUNTS ARE INCLUDED IN COLUMN (C) AND THEN REALLOCATED ON LINE 24A TO THE PROPER FUNCTIONAL EXPENSE CATEGORIES. FORM 990, PART XI, LINE 9: OTHER CHANGES IN NET ASSETS RELATES TO THE CLOSE OUT OF INTERCOMPANY ACCOUNTS PAYABLE AND RECEIVABLE (DUE TO/DUE FROM) IN THE AMOUNT OF $194,310,919 AND $-28,527 IN GRANT REFUND RECLASS. H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE HOSPITAL INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 PATIENT CARE FL 501(C)(3) LINE 3 H LEE MOFFITT CANCER CTR & RES INST INC 0 H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 592451713 PARENT-RESEARCH FL 501(C)(3) LINE 7 N/A 0 H LEE MOFFITT CANCER CTR & RESEARCH INSTITUTE FOUNDATION INC 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238636 FUNDRAISING FL 501(C)(3) LINE 7 H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT REAL ESTATE HOLDING CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 923387708 HOLDING TITLE FL 501(C)(2) H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT LIFESCIENCES CAMPUS MANAGEMENT CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 923388291 REAL ESTATE PROPERTY MANAGEMENT FL 501(C)(3) LINE 12A, I H LEE MOFFITT CANCER CTR & RES INST INC 0 MOFFITT TECHNOLOGIES CORPORATION 12902 MAGNOLIA DRIVE TAMPA FL 33612 300332914 TECHNOLOGY MANAGEMENT FL N/A C 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1